Trial Profile
A Prospective, Six-Year Followup of Silodosin Monotherapy for the Treatment of Luts/Bph: What Are the Factors for Continuation or Withdrawal?
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2015
Price :
$35
*
At a glance
- Drugs Silodosin (Primary)
- Indications Benign prostatic hyperplasia; Lower urinary tract symptoms
- Focus Adverse reactions; Therapeutic Use
- 05 Nov 2015 New trial record
- 09 Oct 2015 Results presented at the 45th Annual Meeting of the International Continence Society